Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Oncology Letters|May 20, 2017
Clinical effect of immunophenotyping on the prognosis of multiple myeloma patients treated with bortezomibNoriyoshi Iriyama, Katsuhiro Miura, Yoshihiro Hatta, et al.
Virchows Archiv : an International Journal of Pathology|July 27, 2016
A cyclin D1-negative mantle cell lymphoma with an IGL-CCND2 translocation that relapsed with blastoid morphology and aggressive clinical behaviorDaisuke Kurita, Kengo Takeuchi, Sumiko Kobayashi, et al.
European Journal of Haematology|September 21, 2022
von Willebrand factor activity levels are influenced by driver mutation status in polycythemia vera and essential thrombocythemia patients with well-controlled platelet countsKazuhide Iizuka, Soji Morishita, Yuji Nishizaki, et al.
Cancer Diagnosis & Prognosis|April 11, 2022
Maintenance Therapy With Bortezomib and Dexamethasone for Transplant-ineligible Patients With Multiple MyelomaYurika Noguchi, Noriyoshi Iriyama, Hiromichi Takahashi, et al.
Therapeutic Drug Monitoring|July 20, 2019
Increased Arbekacin Clearance in Patients With Febrile NeutropeniaTakahiro Nakayama, Masayuki Chuma, Naohiro Tochikura, et al.
International Journal of Hematology|December 31, 2015
Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignanciesKatsuhiro Miura, Masaru Nakagawa, Hiromichi Takahashi, et al.
Plos One|October 27, 2011
Epstein-Barr virus induces erosive arthritis in humanized miceYoshikazu Kuwana, Masami Takei, Misako Yajima, et al.
International Journal of Hematology|March 18, 2015
Dose-intensified CHOP with rituximab (R-Double-CHOP) followed by consolidation high-dose chemotherapies for patients with advanced diffuse large B-cell lymphomaDaisuke Kurita, Katsuhiro Miura, Masaru Nakagawa, et al.
Leukemia & Lymphoma|April 14, 2016
Negative impact of concurrent overexpression of MYC and BCL2 in patients with advanced diffuse large B-cell lymphoma treated with dose-intensified immunochemotherapyHiromichi Takahashi, Katsuhiro Miura, Masaru Nakagawa, et al.
Leukemia & Lymphoma|September 22, 2015
Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapyKatsuhiro Miura, Hiromichi Takahashi, Masaru Nakagawa, et al.
Pageof 10